These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33232507)

  • 1. Immune checkpoint inhibitor therapy-associated encephalitis: a case series and review of the literature.
    Stuby J; Herren T; Schwegler Naumburger G; Papet C; Rudiger A
    Swiss Med Wkly; 2020 Nov; 150():w20377. PubMed ID: 33232507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephalitis Induced by Immune Checkpoint Inhibitors: A Systematic Review.
    Velasco R; Villagrán M; Jové M; Simó M; Vilariño N; Alemany M; Palmero R; Martínez-Villacampa MM; Nadal E; Bruna J
    JAMA Neurol; 2021 Jul; 78(7):864-873. PubMed ID: 33720308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-related encephalitis after immune checkpoint inhibitor therapy.
    Buckley MW; Balaji Warner A; Brahmer J; Cappelli LC; Sharfman WH; Fuchs E; Kang H; Forde PM; Gladstone DE; Ambinder R; Kelly RJ; Lipson EJ; Gojo I; Lee EJ; Johnson TP; Saidha S; Llinas R; Ostrow LW; Naidoo J; Probasco JC
    Oncologist; 2024 Jul; ():. PubMed ID: 39066587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nivolumab-induced seronegative encephalitis.
    Cabral G; Ladeira F; Gil N
    J Neuroimmunol; 2020 Oct; 347():577350. PubMed ID: 32768895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment.
    Bir Yucel K; Sutcuoglu O; Yazıcı O; Yıldız Y; Şenol E; Uner A
    J Oncol Pharm Pract; 2023 Apr; 29(3):760-763. PubMed ID: 35938177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nivolumab induced encephalopathy in a man with metastatic renal cell cancer: a case report.
    Kopecký J; Kubeček O; Geryk T; Slováčková B; Hoffmann P; Žiaran M; Priester P
    J Med Case Rep; 2018 Sep; 12(1):262. PubMed ID: 30217214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of immune checkpoint inhibitor-induced encephalitis and comparison with HSV-1 and anti-LGI1 encephalitis: A retrospective multicentre cohort study.
    Müller-Jensen L; Zierold S; Versluis JM; Boehmerle W; Huehnchen P; Endres M; Mohr R; Compter A; Blank CU; Hagenacker T; Meier F; Reinhardt L; Gesierich A; Salzmann M; Hassel JC; Ugurel S; Zimmer L; Banks P; Spain L; Soon JA; Enokida T; Tahara M; Kähler KC; Seggewiss-Bernhardt R; Harvey C; Long GV; Schöberl F; von Baumgarten L; Hundsberger T; Schlaak M; French LE; Knauss S; Heinzerling LM
    Eur J Cancer; 2022 Nov; 175():224-235. PubMed ID: 36155116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephalitis in a patient with hypopharynx cancer treated with immune checkpoint inhibitors and radiotherapy: a case report and review of the literature.
    Kang Y; Zhen H; Ma N; Zhao H; Cao B
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):16239-16246. PubMed ID: 37676267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis.
    Larkin J; Chmielowski B; Lao CD; Hodi FS; Sharfman W; Weber J; Suijkerbuijk KPM; Azevedo S; Li H; Reshef D; Avila A; Reardon DA
    Oncologist; 2017 Jun; 22(6):709-718. PubMed ID: 28495807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial fibrillary acidic protein (GFAP) associated autoimmune meningoencephalitis in a patient receiving nivolumab.
    Kapadia RK; Ney DE; Hannan M; Farley M; Pastula DM; Piquet AL
    J Neuroimmunol; 2020 Jul; 344():577259. PubMed ID: 32416558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encephalitis related to immunotherapy for lung cancer: Analysis of a multicenter cohort.
    Sanchis-Borja M; Ricordel C; Chiappa AM; Hureaux J; Odier L; Jeannin G; Descourt R; Gervais R; Monnet I; Auliac JB; Chouaïd C
    Lung Cancer; 2020 May; 143():36-39. PubMed ID: 32200139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint inhibitors-associated cranial nerves involvement: a systematic literature review on 136 patients.
    Pichon S; Aigrain P; Lacombe C; Lemarchant B; Ledoult E; Koether V; Leurs A; Zebian G; Launay D; Gachet B; Levy C
    J Neurol; 2024 Oct; 271(10):6514-6525. PubMed ID: 39225744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.
    Kumar V; Shinagare AB; Rennke HG; Ghai S; Lorch JH; Ott PA; Rahma OE
    Oncologist; 2020 Jun; 25(6):505-514. PubMed ID: 32043699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid Interleukin-6 in Immune Checkpoint Inhibitor-Induced Autoimmune Meningoencephalitis.
    Mizukami T; Masuda T; Kimura N; Uchida H; Jikumaru M; Hanaoka T; Matsubara E
    Tohoku J Exp Med; 2022 Sep; 258(2):159-165. PubMed ID: 36047134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system complications associated with immune checkpoint inhibitors.
    Vogrig A; Muñiz-Castrillo S; Joubert B; Picard G; Rogemond V; Marchal C; Chiappa AM; Chanson E; Skowron F; Leblanc A; Ducray F; Honnorat J
    J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):772-778. PubMed ID: 32312871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nivolumab-Associated Acute Demyelinating Encephalitis: A Case Report and Literature Review.
    Zafar Z; Vogler C; Hudali T; Bhattarai M
    Clin Med Res; 2019 Jun; 17(1-2):29-33. PubMed ID: 31160476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atezolizumab-associated encephalitis in metastatic lung adenocarcinoma: a case report.
    Yamaguchi Y; Nagasawa H; Katagiri Y; Wada M
    J Med Case Rep; 2020 Jul; 14(1):88. PubMed ID: 32620173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of repetitive seizures following immune checkpoint inhibitor therapy as a feature of autoimmune encephalitis.
    Takebayashi Y; Neshige S; Hayashi T; Aoki S; Ueno H; Iida K; Maruyama H
    Epileptic Disord; 2021 Oct; 23(5):733-738. PubMed ID: 34519645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Adenosine Deaminase Levels in the Cerebrospinal Fluid in Immune Checkpoint Inhibitor-induced Autoimmune Encephalitis.
    Fujiwara S; Mimura N; Yoshimura H; Fujimoto D; Ito M; Mori R; Ito J; Tomii K; Kawamoto M; Kohara N
    Intern Med; 2019 Oct; 58(19):2871-2874. PubMed ID: 31243206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune Encephalitis following Checkpoint Inhibitor Therapy in a Patient with Metastatic Melanoma in Complete Remission.
    Civardi G; Medioli A; Braghieri C; Ambroggi M; Immovilli P; Orsucci S; Contini P; Aronica G; Cavanna L
    Medicina (Kaunas); 2024 Apr; 60(5):. PubMed ID: 38792910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.